Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation
NCT01290328
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
100
Enrollment
INDIV
Sponsor class
Stopped
low enrollment, termination of funding
Conditions
Anemia
Interventions
DRUG:
Epoetin Alfa
Sponsor
Mehrotra, Anita, M.D.
Collaborators
[object Object]